Our Partners

The SJSU SCILL consortium with the collaborative effort of Stanford University, UC Santa Cruz, Amgen, SRI International, Dorian Therapeutics, Neurona, NeuCyte, Novo Nordisk etc. prepare and train graduate-level students in stem cell research.

The Host Institutions offer a diverse array of research interests in Regenerative Medicine with the state-of-the-art-technology. Each institution works closely with the interns to provide them with experience and laboratory skills that will allow them to take advantage of career opportunities in stem cell research.

• Stem Cell Biology and Regenerative Medicine Institute at Stanford University

  • The Stem Cell Biology and Regenerative Medicine Institute at Stanford University was established in 2003 to build on Stanford's leadership in stem cell science and to set the foundations for the creation of a new field of science: regenerative medicine. Under the direction of renowned stem cell researcher Dr. Irving Weissman, the institute is devoted to exploring the how stem cells are created, the mechanisms by which they are regulated and how they devolve into specialized cells.

• Institute for the Biology of Stem Cells at UC Santa Cruz

  • Stem cell research at Institute for the Biology of Stem Cells at UC Santa Cruz focuses on the basic biological systems operating in the processes of self-renewal and differentiation of stem cells.

    Stem cells hold great promise for curing or mitigating the effects of many diseases and injuries. But before a single clinical trial can commence, basic research must take place to uncover the pathways, mechanisms, and cellular effects of potential stem-cell-based cures. Basic research is also needed to overcome technological hurdles, such as how to ensure that stem cells work effectively when injected into a living organism. Investment in basic research of the kind done at the IBSC is an essential step toward stem-cell-based cures.

    The Center for Biomolecular Science & Engineering administers the UCSC Institute for the Biology of Stem Cells.

• SRI International

  • For 75 years, SRI has led the discovery and design of ground-breaking products, technologies and industries – collaborating across technical and scientific disciplines to generate real innovation and create high value for our clients.

• Dorian Therapeutics

  • Dorian Therapeutics is the leading company working on senoblockers, a new class of therapeutics that can rejuvenate cells and tissues. Based on a patented technology developed at Stanford University, Dorian’s team is bringing to the clinic an innovative solution for age-associated diseases.

• Neurona Therapeutics

  • Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease.

• NeuCyte

  • Bridging the drug discovery path with translatable neuroscience. NeuCyte is an innovative biotechnology company focused on CNS drug discovery.

• Amgen

  • Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.

• Novo Nordisk

  • By combining  innovation and commercial excellence, Novo Nordisk draws upon insights from patients and partners to transform bold ideas into life-saving and preventive medicines.

• Tenaya Therapeutics

  • Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease.

• Exir Bio

  • Exir Bio is modernizing drug discovery. Their mission is to replace, reduce and refine the use of monkeys in boimedical research.  

Internship Coordinators provide onsite coordination and supervision for students during their year-long research internship. Coordinators make sure that interns are added to assurance forms and protocols and overall supervise the intern performance and adaptability to the internship lab. Coordinators keep close communication with SJSU mentors to optimize interns performance and satisfaction of both interns and internship lab mentors and PI’s.

Each institution has unique internship opportunities and requirements. It is the Internship Coordinator’s responsibility to assure knowledge and experience in a variety of techniques and to manage the unique opportunities and requirements during the year-long internship.

Cynthia Klein
Stanford University

TBD
University of California Santa Cruz

Dr. Wayne Poon
NeuCyte

Dr. Roland Wu
Amgen

Dr. Maddalena Adorno
Dorian Therapeutics

Dr. Danuta Sastre
SRI International

Dr. Michael Watson
Neurona Therapeutics

Theresa Martinez
Novo Nordisk

Dr. Morteza Roodgar
Exir Bio

TBD
Tenaya Therapeutics

The Internship research mentors provide in-depth research internship experiences for the students. They have primary responsibility for development and performance of each student’s research plan, and guidance in preparation of the internship research report.

Stanford University

Dr. Eugene Butcher
Professor

Dr. Michael Clarke
Professor

Dr. Kyle Loh
Assistant Professor

Dr. Hiromitsu Nakauchi
Professor

Dr. Max Diehn
Professor

Dr. Agnieszka Czechowicz
Assistant Professor

Dr. Michael Longaker
Professor

Dr. Ravi Majeti
Professor

Dr. Kathleen Sakamoto
Professor

Dr. Theo Palmer
Professor

Dr. Mathew Porteus
Professor

Dr. Maria-Grazia Roncarola
Professor

Dr. Julien Sage
Professor

Dr. Birgitt Schuele
Associate Professor (Researcher)

Dr. Vittorio Sebastiano
Associate Professor

Dr. Alice Bertaina
Associate Professor

Dr. Irving Weissman
Professor

Dr. Marius Wernig
Professor

Dr. Albert Wu
Assistant Professor

Dr. Fan Yang
Associate Professor

University of California, Santa Cruz

Dr. Bin Chen
Professor

Dr. Camilla Forsberg
Professor

Dr. Sofie Salama
Professor 

Dr. Daniel Kim
Assistant Professor

Dr. Ali Shariati
Assistant Professor

Dr. Shaheen Sikandar
Assistant Professor

Neurona Therapeutics

Dr. Michael Watson
Associate Director, Assay Development and Quality Control

Dorian Therapeutics

Dr. Maddalena Adorno, Ph.D.
Co-founder, CEO

Dr. Benedetta di Robilant, Ph.D.
Co-founder, CSO 

Amgen

Dr. Roland Wu, MD
Scientist 

SRI International 

Dr. Danuta Sastre, Ph.D.
Program Director, Biology 

Novo Nordisk

Dr. Sherry Hikita
Project Director, Cell Therapy R&D 

Exir Bio

Dr. Morteza Roodgar
Chief Scientific Advisor 

NeuCyte

Dr. Wayne Poon
Head of Neuroscience

Tenaya

TBD
TBD